Wellgistics Health (NASDAQ:WGRX) Issues Quarterly Earnings Results

Wellgistics Health (NASDAQ:WGRX) posted its earnings results on Friday. The company reported ($0.13) EPS for the quarter, Zacks reports. Wellgistics Health had a negative return on equity of 1,617.25% and a negative net margin of 228.17%.

Wellgistics Health Stock Up 14.3%

Wellgistics Health stock opened at $0.14 on Friday. The stock’s 50 day moving average price is $0.28 and its 200 day moving average price is $0.57. Wellgistics Health has a 1-year low of $0.11 and a 1-year high of $7.04. The company has a market cap of $12.29 million and a PE ratio of -0.12. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.39 and a quick ratio of 0.16.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Wellgistics Health in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Wellgistics Health currently has an average rating of “Sell”.

Hedge Funds Weigh In On Wellgistics Health

A number of institutional investors and hedge funds have recently made changes to their positions in WGRX. Raymond James Financial Inc. increased its holdings in Wellgistics Health by 593.8% in the third quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock valued at $52,000 after buying an additional 50,000 shares in the last quarter. XTX Topco Ltd increased its holdings in Wellgistics Health by 195.1% during the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after acquiring an additional 70,137 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in Wellgistics Health by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock worth $195,000 after acquiring an additional 218,170 shares during the last quarter.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.